Ítem
Acceso Abierto

Challenges in the diagnosis and management of acromegaly: a focus on comorbidities

Título de la revista
Autores
Abreu, Alin
Tovar, Alejandro Pinzón
Castellanos, Rafael
Valenzuela, Alex
Giraldo, Claudia Milena Gómez
Pinedo, Alejandro Castellanos
Guerrero, Doly Pantoja
Barrera, Carlos Alfonso Builes
Franco, Humberto Ignacio
Ribeiro-Oliveira, Antônio

Archivos
Fecha
2016

Directores

ISSN de la revista
Título del volumen
Editor
Springer New York LLC

Buscar en:

Métricas alternativas

Resumen
Abstract
Introduction: Acromegaly is a rare, insidious disease resulting from the overproduction of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), and is associated with a range of comorbidities. The extent of associated complications and mortality risk is related to length of exposure to the excess GH and IGF-1, thus early diagnosis and treatment is imperative. Unfortunately, acromegaly is often diagnosed late, when patients already have a wide range of comorbidities. The presence of comorbid conditions contributes significantly to patient morbidity/mortality and impaired quality of life. Methods: We conducted a retrospective literature review for information relating to the diagnosis of acromegaly, and its associated comorbidities using PubMed. The main aim of this review is to highlight the issues of comorbidities in acromegaly, and to reinforce the importance of early diagnosis and treatment. Findings and conclusions: Successful management of acromegaly goes beyond treating the disease itself, since many patients are diagnosed late in disease evolution, they present with a range of comorbid conditions, such as cardiovascular disease, diabetes, hypertension, and sleep apnea. It is important that patients are screened carefully at diagnosis (and thereafter), for common associated complications, and that biochemical control does not become the only treatment goal. Mortality and morbidities in acromegaly can be reduced successfully if patients are treated using a multimodal approach with comprehensive comorbidity management. © 2016, The Author(s).
Palabras clave
Keywords
Growth hormone , left ventricular , Somatomedin c , left ventricular , Acromegaly , Arthropathy , Cardiovascular disease , Comorbidity , Craniofacial development , Endocrine disease , Hormone synthesis , Human , Lung disease , Malignant neoplastic disease , Mental disease , Metabolic disorder , Morbidity , Mortality , Neurologic disease , Priority journal , Quality of life , Retrospective study , Review , Rheumatic disease , Adenoma , Cardiovascular diseases , Carpal tunnel syndrome , Comorbidity , Complication , Diabetes mellitus , Disease management , Growth hormone-secreting pituitary adenoma , Headache , Heart failure , Hypertension , Hypertrophy , Macroglossia , Osteoarthritis , Prognosis , Sleep apnea syndromes , Vision disorders , Adenoma , Cardiovascular diseases , Carpal tunnel syndrome , Comorbidity , Diabetes mellitus , Disease management , Growth hormone-secreting pituitary adenoma , Headache , Heart failure , Humans , Hypertension , Hypertrophy , Macroglossia , Osteoarthritis , Prognosis , Sleep apnea syndromes , Vision disorders , Acromegaly comorbidities , Acromegaly diagnosis , Latin america
Buscar en:
Colecciones